Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration
Purpose: - The purpose of this study was to evaluate the effect of intravitreally administered bevacizumab on untreated vascularized pigment epithelium detachment (PED) in sub- or juxtafoveal occult choroidal neovascularization as a result of age-related macular degeneration. - Methods: - In thi...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
October 2010
|
| In: |
Retina
Year: 2010, Jahrgang: 30, Heft: 9, Pages: 1420-1425 |
| ISSN: | 1539-2864 |
| DOI: | 10.1097/IAE.0b013e3181d87e97 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/IAE.0b013e3181d87e97 Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/retinajournal/Abstract/2010/10000/INTRAVITREAL_BEVACIZUMAB_IN_VASCULAR_PIGMENT.10.aspx 
|
| Verfasserangaben: | Thomas Ach, Alexandra E. Hoeh, Mira Ruppenstein, Florian T.A. Kretz, Stefan Dithmar |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1822513022 | ||
| 003 | DE-627 | ||
| 005 | 20240326080301.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221115s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/IAE.0b013e3181d87e97 |2 doi | |
| 035 | |a (DE-627)1822513022 | ||
| 035 | |a (DE-599)KXP1822513022 | ||
| 035 | |a (OCoLC)1389822662 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ach, Thomas |d 1976- |e VerfasserIn |0 (DE-588)1146840926 |0 (DE-627)1008273554 |0 (DE-576)255664494 |4 aut | |
| 245 | 1 | 0 | |a Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration |c Thomas Ach, Alexandra E. Hoeh, Mira Ruppenstein, Florian T.A. Kretz, Stefan Dithmar |
| 264 | 1 | |c October 2010 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.11.2022 | ||
| 520 | |a Purpose: - The purpose of this study was to evaluate the effect of intravitreally administered bevacizumab on untreated vascularized pigment epithelium detachment (PED) in sub- or juxtafoveal occult choroidal neovascularization as a result of age-related macular degeneration. - Methods: - In this retrospective study, 28 untreated eyes of 26 patients (4 men, 22 women; mean age, 74.6 ± 7.2 years) with PED and sub- or juxtafoveal occult choroidal neovascularization as a result of age-related macular degeneration and additional intra- and/or subretinal fluid were treated with intravitreal injections of 1.25 mg bevacizumab. Baseline and follow-up visits included best-corrected visual acuity, complete ophthalmic examination, and Stratus optical coherence tomography. Fluorescein angiography was performed at baseline. Reinjections were performed if intra- and/or subretinal fluid persisted or recurred or PED increased. - Results: - Patients received 3.2 ± 1.8 injections (follow-up 37.9 ± 18.3 weeks). Mean maximum PED height showed a tendency to decrease (372 ± 150.5 μm to 290.3 ± 189 μm; P = 0.094). In 14 eyes (53.8%), PED height was reduced at last visit, including complete flattening in 1 eye. Mean visual acuity remained stable (0.58 ± 0.30 logarithm of the minimum angle of resolution to 0.58 ± 0.37 logarithm of the minimum angle of resolution; P = 0.905). Pigment epithelium detachment response to treatment did not correlate with baseline PED height or visual acuity at baseline or at the last visit. One patient sustained a retinal pigment epithelium rip, and another patient sustained an extensive subretinal hemorrhage. - Conclusion: - During bevacizumab therapy, mean PED height decreases in 50% of patients. No predictive factors for the response of PED to bevacizumab treatment could be identified. Treatment of PED with bevacizumab might result in a long-term functional benefit compared with the natural course. | ||
| 700 | 1 | |a Höh, Alexandra E. |d 1981- |e VerfasserIn |0 (DE-588)133382435 |0 (DE-627)544038282 |0 (DE-576)276066839 |4 aut | |
| 700 | 1 | |a Ruppenstein, Mira Katharina |e VerfasserIn |0 (DE-588)1025546806 |0 (DE-627)722909306 |0 (DE-576)370488881 |4 aut | |
| 700 | 1 | |a Kretz, Florian T. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dithmar, Stefan |e VerfasserIn |0 (DE-588)113213670 |0 (DE-627)55785637X |0 (DE-576)289755662 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Retina |d Philadelphia, Pa. [u.a.] : Lippincott, Williams & Wilkins, 1981 |g 30(2010), 9, Seite 1420-1425 |h Online-Ressource |w (DE-627)341912247 |w (DE-600)2071014-8 |w (DE-576)103373586 |x 1539-2864 |7 nnas |a Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration |
| 773 | 1 | 8 | |g volume:30 |g year:2010 |g number:9 |g pages:1420-1425 |g extent:6 |a Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration |
| 856 | 4 | 0 | |u https://doi.org/10.1097/IAE.0b013e3181d87e97 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.lww.com/retinajournal/Abstract/2010/10000/INTRAVITREAL_BEVACIZUMAB_IN_VASCULAR_PIGMENT.10.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221115 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 113213670 |a Dithmar, Stefan |m 113213670:Dithmar, Stefan |d 50000 |e 50000PD113213670 |k 0/50000/ |p 5 |y j | ||
| 998 | |g 1025546806 |a Ruppenstein, Mira Katharina |m 1025546806:Ruppenstein, Mira Katharina |d 910000 |d 910900 |e 910000PR1025546806 |e 910900PR1025546806 |k 0/910000/ |k 1/910000/910900/ |p 3 | ||
| 998 | |g 133382435 |a Höh, Alexandra E. |m 133382435:Höh, Alexandra E. |d 910000 |d 910900 |e 910000PH133382435 |e 910900PH133382435 |k 0/910000/ |k 1/910000/910900/ |p 2 | ||
| 999 | |a KXP-PPN1822513022 |e 4211294075 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 15.11.2022"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1822513022","language":["eng"],"title":[{"title":"Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration","title_sort":"Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration"}],"person":[{"family":"Ach","given":"Thomas","display":"Ach, Thomas","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Alexandra E.","family":"Höh","role":"aut","display":"Höh, Alexandra E.","roleDisplay":"VerfasserIn"},{"family":"Ruppenstein","given":"Mira Katharina","roleDisplay":"VerfasserIn","display":"Ruppenstein, Mira Katharina","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Kretz, Florian T. A.","role":"aut","family":"Kretz","given":"Florian T. A."},{"family":"Dithmar","given":"Stefan","display":"Dithmar, Stefan","roleDisplay":"VerfasserIn","role":"aut"}],"physDesc":[{"extent":"6 S."}],"relHost":[{"origin":[{"publisherPlace":"Philadelphia, Pa. [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1981-","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedKey":"1981"}],"id":{"issn":["1539-2864"],"zdb":["2071014-8"],"eki":["341912247"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Retina","subtitle":"the journal of retinal and vitreous diseases","title":"Retina"}],"pubHistory":["1.1981 -"],"part":{"year":"2010","issue":"9","pages":"1420-1425","text":"30(2010), 9, Seite 1420-1425","volume":"30","extent":"6"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 11.06.2019"],"disp":"Intravitreal Bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degenerationRetina","recId":"341912247","language":["eng"]}],"origin":[{"dateIssuedDisp":"October 2010","dateIssuedKey":"2010"}],"id":{"doi":["10.1097/IAE.0b013e3181d87e97"],"eki":["1822513022"]},"name":{"displayForm":["Thomas Ach, Alexandra E. Hoeh, Mira Ruppenstein, Florian T.A. Kretz, Stefan Dithmar"]}} | ||
| SRT | |a ACHTHOMASHINTRAVITRE2010 | ||